Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Clearpoint Neuro Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
CLPT
Nasdaq
3845
https://www.clearpointneuro.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Clearpoint Neuro Inc
ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
- Apr 16th, 2024 8:05 pm
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency
- Mar 19th, 2024 12:07 pm
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Annual Results: Here's What Analysts Are Forecasting For This Year
- Mar 15th, 2024 10:43 am
ClearPoint Neuro Full Year 2023 Earnings: Beats Expectations
- Mar 14th, 2024 10:41 am
ClearPoint Neuro Inc Reports Robust Revenue Growth in Q4 and Full-Year 2023
- Mar 12th, 2024 9:39 pm
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results
- Mar 12th, 2024 8:05 pm
Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy System
- Mar 11th, 2024 12:00 pm
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024
- Mar 1st, 2024 9:05 pm
ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock
- Feb 29th, 2024 1:00 pm
ClearPoint Neuro Launches Proposed Public Offering of Common Stock
- Feb 28th, 2024 9:45 pm
ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model
- Feb 21st, 2024 9:05 pm
ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo
- Jan 24th, 2024 9:05 pm
ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe
- Jan 22nd, 2024 9:05 pm
ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System
- Jan 16th, 2024 1:00 pm
ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue
- Jan 8th, 2024 9:05 pm
Those who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 365%
- Dec 19th, 2023 11:10 am
Are Investors Undervaluing ClearPoint Neuro, Inc. (NASDAQ:CLPT) By 41%?
- Nov 22nd, 2023 10:46 am
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q3 2023 Earnings Call Transcript
- Nov 10th, 2023 7:38 pm
ClearPoint Neuro Reports Third Quarter 2023 Results
- Nov 9th, 2023 9:05 pm
ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023
- Oct 26th, 2023 8:05 pm
Scroll